A citation-based method for searching scientific literature

M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans, F Lehmann-Horn, K Jurkat-Rott, T Brandt, J C Jen, K Jahn. Neurology 2011
Times Cited: 107







List of co-cited articles
1133 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
M Strupp, R Kalla, M Dichgans, T Freilinger, S Glasauer, T Brandt. Neurology 2004
142
36

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
M Strupp, O Schüler, S Krafczyk, K Jahn, F Schautzer, U Büttner, T Brandt. Neurology 2003
153
35

The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
111
30

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
R A Ophoff, G M Terwindt, M N Vergouwe, R van Eijk, P J Oefner, S M Hoffman, J E Lamerdin, H W Mohrenweiser, D E Bulman, M Ferrari,[...]. Cell 1996
26

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
86
30

Primary episodic ataxias: diagnosis, pathogenesis and treatment.
J C Jen, T D Graves, E J Hess, M G Hanna, R C Griggs, R W Baloh. Brain 2007
197
24

4-aminopyridine and cerebellar gait: a retrospective case series.
Roman Schniepp, Max Wuehr, Maximilian Neuhaeusser, Ann Kathrin Benecke, Christine Adrion, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2012
40
60

Clinical spectrum of episodic ataxia type 2.
J Jen, G W Kim, R W Baloh. Neurology 2004
173
22

4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Roger Kalla, Stefan Glasauer, Ulrich Büttner, Thomas Brandt, Michael Strupp. Brain 2007
75
29

A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Jens Claassen, Rainer Spiegel, Roger Kalla, Mary Faldon, Christopher Kennard, Chotipat Danchaivijitr, Stanislaw Bardins, Nicole Rettinger, Erich Schneider, Thomas Brandt,[...]. J Neurol Neurosurg Psychiatry 2013
48
45

Hereditary paroxysmal ataxia: response to acetazolamide.
R C Griggs, R T Moxley, R A Lafrance, J McQuillen. Neurology 1978
158
18

Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Jens Claassen, Julian Teufel, Roger Kalla, Rainer Spiegel, Michael Strupp. J Neurol 2013
20
90

Detection of floccular hypometabolism in downbeat nystagmus by fMRI.
R Kalla, A Deutschlander, K Hufner, T Stephan, K Jahn, S Glasauer, T Brandt, M Strupp. Neurology 2006
59
28

Downbeat nystagmus: aetiology and comorbidity in 117 patients.
J N Wagner, M Glaser, T Brandt, M Strupp. J Neurol Neurosurg Psychiatry 2008
92
18


Episodic ataxia type 2.
Michael Strupp, Andreas Zwergal, Thomas Brandt. Neurotherapeutics 2007
95
14

4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
S Glasauer, R Kalla, U Büttner, M Strupp, T Brandt. J Neurol Neurosurg Psychiatry 2005
56
25

Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series.
Michael Strupp, Julian Teufel, Maximilian Habs, Regina Feuerecker, Carolin Muth, Bart P van de Warrenburg, Thomas Klopstock, Katharina Feil. J Neurol 2013
45
31

Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.
Michael Strupp, Matthew J Thurtell, Aasef G Shaikh, Thomas Brandt, David S Zee, R John Leigh. J Neurol 2011
61
21

Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
Michael Strupp, Vera Carina Zingler, Viktor Arbusow, Daniel Niklas, Klaus Peter Maag, Marianne Dieterich, Sandra Bense, Diethilde Theil, Klaus Jahn, Thomas Brandt. N Engl J Med 2004
208
13

Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Roger Kalla, Rainer Spiegel, Jens Claassen, Stanislavs Bardins, Ales Hahn, Erich Schneider, Nicole Rettinger, Stefan Glasauer, Thomas Brandt, Michael Strupp. J Neuroophthalmol 2011
28
46

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.
Ichiro Miyai, Mizuki Ito, Noriaki Hattori, Masahito Mihara, Megumi Hatakenaka, Hajime Yagura, Gen Sobue, Masatoyo Nishizawa. Neurorehabil Neural Repair 2012
90
14

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
T A Zesiewicz, P E Greenstein, K L Sullivan, L Wecker, A Miller, I Jahan, R Chen, S L Perlman. Neurology 2012
63
20

Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Tracey D Graves, Yoon-Hee Cha, Angelika F Hahn, Richard Barohn, Mohammed K Salajegheh, Robert C Griggs, Brian N Bundy, Joanna C Jen, Robert W Baloh, Michael G Hanna. Brain 2014
52
25

Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia.
A Escayg, M De Waard, D D Lee, D Bichet, P Wolf, T Mayer, J Johnston, R Baloh, T Sander, M H Meisler. Am J Hum Genet 2000
267
12

Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.
J C Jen, J Wan, T P Palos, B D Howard, R W Baloh. Neurology 2005
219
12

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.
O Zhuchenko, J Bailey, P Bonnen, T Ashizawa, D W Stockton, C Amos, W B Dobyns, S H Subramony, H Y Zoghbi, C C Lee. Nat Genet 1997
12


Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Raphael Hourez, Laurent Servais, David Orduz, David Gall, Isabelle Millard, Alban de Kerchove d'Exaerde, Guy Cheron, Harry T Orr, Massimo Pandolfo, Serge N Schiffmann. J Neurosci 2011
85
14

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
99
12

Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2.
Elide Mantuano, Silvia Romano, Liana Veneziano, Cinzia Gellera, Barbara Castellotti, Sara Caimi, Daniela Testa, Margherita Estienne, Giovanna Zorzi, Marianna Bugiani,[...]. J Neurol Sci 2010
48
22

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
D L Browne, S T Gancher, J G Nutt, E R Brunt, E A Smith, P Kramer, M Litt. Nat Genet 1994
574
11

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
R Kalla, S Glasauer, F Schautzer, N Lehnen, U Büttner, M Strupp, T Brandt. Neurology 2004
55
20

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
894
11

Intensive coordinative training improves motor performance in degenerative cerebellar disease.
W Ilg, M Synofzik, D Brötz, S Burkard, M A Giese, L Schöls. Neurology 2009
138
11

Dalfampridine in patients with downbeat nystagmus--an observational study.
Jens Claassen, Katharina Feil, Stanislav Bardins, Julian Teufel, Rainer Spiegel, Roger Kalla, Erich Schneider, Klaus Jahn, Roman Schniepp, Michael Strupp. J Neurol 2013
17
64

Aminopyridines for the treatment of neurologic disorders.
Michael Strupp, Julian Teufel, Andreas Zwergal, Roman Schniepp, Kamran Khodakhah, Katharina Feil. Neurol Clin Pract 2017
26
42

4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.
Roman Schniepp, Max Wuehr, Nibal Ackl, Adrian Danek, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2011
23
43

Vestibular paroxysmia: diagnostic features and medical treatment.
K Hüfner, D Barresi, M Glaser, J Linn, C Adrion, U Mansmann, T Brandt, M Strupp. Neurology 2008
86
11

4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
O Kremmyda, A Zwergal, C la Fougère, T Brandt, K Jahn, M Strupp. J Neurol 2013
20
50

A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia.
Raffaella Zannolli, Sabrina Buoni, Gianni Betti, Sara Salvucci, Alessandro Plebani, Annarosa Soresina, Maria C Pietrogrande, Silvana Martino, Vincenzo Leuzzi, Andrea Finocchi,[...]. Mov Disord 2012
47
21

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.
Wilhelmina G Leen, Joerg Klepper, Marcel M Verbeek, Maike Leferink, Tom Hofste, Baziel G van Engelen, Ron A Wevers, Todd Arthur, Nadia Bahi-Buisson, Diana Ballhausen,[...]. Brain 2010
213
10

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
93
10

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Theresa A Zesiewicz, George Wilmot, Sheng-Han Kuo, Susan Perlman, Patricia E Greenstein, Sarah H Ying, Tetsuo Ashizawa, S H Subramony, Jeremy D Schmahmann, K P Figueroa,[...]. Neurology 2018
38
26

A new episodic ataxia syndrome with linkage to chromosome 19q13.
Kevin A Kerber, Joanna C Jen, Hane Lee, Stanley F Nelson, Robert W Baloh. Arch Neurol 2007
34
26

Effects of ablation of flocculus and paraflocculus of eye movements in primate.
D S Zee, A Yamazaki, P H Butler, G Gücer. J Neurophysiol 1981
645
9

Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering.
Catherine J C Weisz, Robert S Raike, Luis E Soria-Jasso, Ellen J Hess. J Neurosci 2005
48
18

KCa channels as therapeutic targets in episodic ataxia type-2.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
72
12

Vestibular migraine: diagnostic criteria.
Thomas Lempert, Jes Olesen, Joseph Furman, John Waterston, Barry Seemungal, John Carey, Alexander Bisdorff, Maurizio Versino, Stefan Evers, David Newman-Toker. J Vestib Res 2012
390
9

The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Taiji Tsunemi, Kinya Ishikawa, Kei Tsukui, Takuro Sumi, Ken Kitamura, Hidehiro Mizusawa. J Neurol Sci 2010
20
45


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.